STAT
OCTOBER 27, 2024
Every day, my inbox bursts with opinions about everything from poop transplants to climate change. When news in medicine happens, someone will inevitably email me offering an op-ed. Except on one topic: the health of the major presidential candidates. Almost no one wants to touch it.
Drug Topics
OCTOBER 27, 2024
A conversation with Lauren Angelo, PharmD, MBA, associate dean of academic affairs and associate professor of pharmacy practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 27, 2024
During an annual checkup, the patient says: “Doc, I saw a commercial about a blood test that can tell if I’ll develop Alzheimer’s. I watched my mother go through it. I want to get tested.” He’s referring to the new Alzheimer’s blood-based biomarkers. Despite not showing any symptoms of Alzheimer’s — he manages his own finances, drives, shops, and cooks elaborate meals for his wife — he’s clearly worried.
Drug Topics
OCTOBER 27, 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
OCTOBER 27, 2024
Here’s the paradox: The most influential set of rules for the foods we eat are the ones most of us ignore. But they still matter for millions of Americans. The Dietary Guidelines for Americans, reviewed and issued by the federal government every five years, have broad impact on what goes into federal nutritional assistance programs, from WIC for women and young children to school lunches to meals for veterans or seniors.
Fierce Healthcare
OCTOBER 27, 2024
Fierce Healthcare reporters returned from Las Vegas on Wednesday after four days packed with meetings, interviews and on-stage conversations all focused on healthcare innovation. | From AI (of course) to PBMs to women's health, here are some topics that got our attention at HLTH 2024.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
OCTOBER 27, 2024
In case you missed it, this week we had stories about the FDA approval of Pfizer's RSV vaccine, vaccines and COVID-19 hospitalization in children, race-based disparities in multimodal analgesia, and more.
The FDA Law Blog
OCTOBER 27, 2024
By Deborah L. Livornese & John W.M. Claud & Charles D. Snow — On October 21, 2024, the Alliance for Natural Health USA (“ANH”), and Meditrend Inc., a homeopathic drug company, filed a complaint on behalf of the homeopathic drug industry against FDA in the District Court for the District of Columbia (“D.D.C.”). This lawsuit presents an interesting reading of the statute at issue, one that is diametrically opposed to that of FDA.
Drug Topics
OCTOBER 27, 2024
PBM reform legislation has progressed further in Congress than ever before.
Med Ed 101
OCTOBER 27, 2024
One of the last hurdles in becoming a licensed pharmacist is the North American Pharmacist Licensure Examination (NAPLEX). NABP recently released information on what to expect for those taking the NAPLEX exam on or after May 1st, 2025. There are some significant changes to the content outline and I outline those changes in the Youtube […] The post NAPLEX Changes in 2025: What Pharmacists Need to Know appeared first on Med Ed 101.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
OCTOBER 27, 2024
The digest was released at the NCPA 2024 Annual Convention and Expo.
BioPharm
OCTOBER 27, 2024
The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet.
Drug Topics
OCTOBER 27, 2024
A conversation with Erin Rexroth, director of marketing at the National Community Pharmacists Association.
Fuld
OCTOBER 27, 2024
In this episode we tackle a crucial topic at the heart of the energy transition: Incumbents vs Disruptors. As the push toward net zero gains momentum, and more companies transition to EVs, traditional energy giants and innovative newcomers are competing to shape the future energy landscape. The question is, how will these dynamics influence the path to sustainability and who will take the lead?
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
OCTOBER 27, 2024
Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.
Therapeutics Education Collaboration
OCTOBER 27, 2024
In episode 589, Mike and James invite Jennifer Young back to the podcast again to talk about a topic that Mike absolutely loves – Vitamin D for everyone. Tune in to hear about all the latest, and the older, evidence. Do you agree we should remove the question mark from the podcast title? Show notes 1) Tools for Practice Vitamin D and Fracture Prevention: Not what it’s cracked up to be?
BioPharm
OCTOBER 27, 2024
Phenotypic screening is a vital tool in drug discovery, enabling scientists to rapidly identify potential drugs early in the discovery pipeline. Kinetic information gained by repeated image acquisition within a physiologically relevant environment provides insight into the dynamic changes which are often overlooked using end-point analysis alone.
BioPharm
OCTOBER 27, 2024
Scaling up the production of viral vectors, particularly adeno-associated virus (AAV), remains wrought with challenges. The issues of low titer and yield, and vector degradation such as unfolding, aggregation and oxidation, need to be better understood and managed by carefully optimizing buffer, pH and excipients. This article addresses key advancements at each step in the workflow — from maximizing titer output at scale upstream to optimized formulation compositions at fill/finish — to support
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharm
OCTOBER 27, 2024
In the rapidly evolving world of cell and gene therapies, innovation is essential if we want to revolutionize medicine. Collaboration in the early stages of development allows us to optimize workflows and apply rigorous quality standards, moving therapies forward without regulatory delays. Our innovative aseptic fluid transfer technologies improve process quality and reduce contamination risks.
BioPharm
OCTOBER 27, 2024
As the FDA signals stronger support for advancing gene therapy approvals, manufacturers face increasing pressure to get to market quickly while maintaining viral vector quality. This article tackles emerging scale-up challenges to efficiency and safety, with an in-depth look at strategies to optimize viral vector production, manage costs, and collaborate on industry standardization and automation.
BioPharm
OCTOBER 27, 2024
The response of tumor cells, such as glioblastomas, to cytotoxic chemotherapeutic compounds is a complex and dynamic process that is crucial to understand in neurooncology research. Using pre-trained neural networks to accurately segment individual cells and classify them as live or dead is a powerful, robust approach for assessing cytotoxicity in glial cell types.
BioPharm
OCTOBER 27, 2024
Live-cell imaging enables acquisition of phase contrast images and provides an ideal platform to study multi-faceted biological paradigms in drug discovery. This is vital to our understanding of human diseases and treatment strategies. The movement of these models towards increasingly complex physiologically relevant ones, including patient-derived cells and induced pluripotent stem cells (iPSCs), has concurrently driven the need for label-free methods that are non-perturbing to deliver deeper b
BioPharm
OCTOBER 27, 2024
Elemental impurity testing is essential to deliver safe drug products to patients and is a regulatory requirement. It is important to assess the risk of elemental impurities from all sources in the manufacturing process, including process equipment, water, container/packaging, raw materials, drug substances, and the final drug product.
BioPharm
OCTOBER 27, 2024
The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet.
BioPharm
OCTOBER 27, 2024
Compendial testing covers a wide array of materials, subjects, and locations designed to create standards and programs that ensure the quality and safety of approved articles for a geographical location or areas such as USP (For the United States market) or Ph Eur (For European markets). The compendia provide monographs and test methods for active ingredients, raw materials, drug products, utilities (water and gases), and packaging components.
BioPharm
OCTOBER 27, 2024
The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet.
BioPharm
OCTOBER 27, 2024
This whitepaper explores the importance of safe cGMP pharma product storage, highlighting challenges CDMOs face with inventory bottlenecks and delays. It examines off-site cGMP storage benefits, including cost savings, flexibility, and compliance, while addressing key factors for maintaining product safety and accessibility.
BioPharm
OCTOBER 27, 2024
Examine the dynamic changes in cell morphology which occur when cells undergo ferroptosis and investigate label-free and fluorescence-based methods of kinetic quantification.
Expert insights. Personalized for you.
127 
Let's personalize your content